Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Renal Insufficiency 2Multiple Myeloma 2Kidney Failure, Chronic 2Kidney Diseases 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 25Tacrolimus 17fludarabine phosphate 14Mycophenolic Acid 14Antilymphocyte Serum 13Cyclosporine 12Methylprednisolone 11Methotrexate 11Melphalan 11Busulfan 11fludarabine 10Radiotherapy 10Peripheral Blood Stem Cell Transplantation 10Filgrastim 10Whole-Body Irradiation 9Sirolimus 9Etoposide 5Therapeutics 4Flow Cytometry 4Cord Blood Stem Cell Transplantation 4Alemtuzumab 4thymoglobulin 3Stem Cell Transplantation 3Rituximab 3Prednisone 3Hematopoietic Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Cyclosporins 3Amplified Fragment Length Polymorphism Analysis 3Leucovorin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Kidney Transplantation × Plasma cell × Clear all
NCT00062621 2013-02-05

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
5 enrolled
GenitourinaryPlasma cell

Graft vs Host Disease, Kidney Diseases, Kidney Failure, Chronic, Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡